NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE Drug Patent Profile
✉ Email this page to a colleague
When do Neomycin And Polymyxin B Sulfates And Hydrocortisone patents expire, and when can generic versions of Neomycin And Polymyxin B Sulfates And Hydrocortisone launch?
Neomycin And Polymyxin B Sulfates And Hydrocortisone is a drug marketed by Amring Pharms, Bausch And Lomb, and Sandoz. and is included in six NDAs.
The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
- What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
- What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 12 |
DailyMed Link: | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE at DailyMed |
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Drug Class | Aminoglycoside Antibacterial Corticosteroid Polymyxin-class Antibacterial |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |